MOIC staff have been contributing and will continue to contribute to a number of key policy and health infrastructure areas. This has included contributing to the development of a Strategic Action Plan for Antimicrobial Resistance, which will be launched in 2019/20. It is anticipated that MOIC will take the lead in the following areas:
- Investigate novel methods of antibiotic use and its impact on healthcare acquired infections.
- Ensure collaboration between the MOIC and industry and assessing the impact of various rapid diagnostics on infection management.